Detalhe da pesquisa
1.
Eyebrow and Eyelash Loss in Patients With Cancer.
J Drugs Dermatol
; 23(5): 327-331, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709698
2.
Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602).
Oncologist
; 28(8): 722-729, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37284847
3.
Hair loss during and after breast cancer therapy.
Support Care Cancer
; 31(3): 186, 2023 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36826602
4.
Measuring symptoms and toxicities: a 35-year experience.
Support Care Cancer
; 31(8): 495, 2023 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37498410
5.
A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2.
Support Care Cancer
; 31(12): 637, 2023 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37847317
6.
Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients.
Support Care Cancer
; 31(12): 717, 2023 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37991653
7.
Factors Associated With Physical Activity Levels in Patients With Breast Cancer.
Oncologist
; 27(10): e811-e814, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35946834
8.
Pregabalin for chemotherapy-induced neuropathy: background and rationale for further study.
Support Care Cancer
; 30(11): 8845-8853, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35953729
9.
A global survey on the utilization of cryotherapy and compression therapy for the prevention of chemotherapy-induced peripheral neuropathy.
Support Care Cancer
; 30(12): 10001-10007, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214880
10.
Financial hardship in breast cancer survivors: a prospective analysis of change in financial concerns over time.
Support Care Cancer
; 31(1): 62, 2022 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36534173
11.
Dietary supplement use and recommendations for discontinuation in an integrative oncology clinic.
Support Care Cancer
; 31(1): 40, 2022 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36525104
12.
Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients.
Cancer
; 127(2): 300-309, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33079393
13.
A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance).
Cancer
; 127(2): 291-299, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33079411
14.
Cutaneous Electroanalgesia for Relief of Chronic and Neuropathic Pain.
N Engl J Med
; 389(2): 158-164, 2023 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37437145
15.
Neuropathy severity at the time of oxaliplatin treatment alteration in patients with colon cancer (Alliance A151912).
Support Care Cancer
; 29(12): 7855-7863, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34176021
16.
Does the placebo effect on hot flashes depend on the placebo dose?
Support Care Cancer
; 29(11): 6741-6749, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33973082
17.
Natural history of nasal vestibulitis associated with paclitaxel, docetaxel, and other chemotherapy agents: a Minnesota Cancer Clinical Trials Network (MNCCTN) study.
Support Care Cancer
; 29(11): 6253-6258, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33851235
18.
Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724).
Support Care Cancer
; 29(2): 833-840, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32500206
19.
A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102.
Support Care Cancer
; 29(1): 387-396, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32372176
20.
Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group.
Support Care Cancer
; 29(6): 2821-2840, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33231809